NCT00533442 - Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Type 1 Diabetes

Interventions

DRUG

Rapamycin

Rapamycin was initiated on day 1 postoperatively, 4mg/day;levels were maintained 5-8ng/ml. Those patients randomized to receive mycophenolate mofetil were given 1gm twice/day starting on the first post-operative day.

DRUG

Mycophenolate Mofetil

MMF 1 gm BID beginning 1st day postoperative day

DRUG

Tacrolimus

Part of standard maintenance.

DRUG

Steroids

Part of standard maintenance

Trial Locations (1)

33136

University of Miami, Miller School of Medicine, Miami